160 related articles for article (PubMed ID: 9930305)
1. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications.
Krisky DM; Marconi PC; Oligino TJ; Rouse RJ; Fink DJ; Cohen JB; Watkins SC; Glorioso JC
Gene Ther; 1998 Nov; 5(11):1517-30. PubMed ID: 9930305
[TBL] [Abstract][Full Text] [Related]
2. Engineering cell lines for production of replication defective HSV-1 gene therapy vectors.
Grant KG; Krisky DM; Ataai MM; Glorioso JC
Biotechnol Bioeng; 2009 Mar; 102(4):1087-97. PubMed ID: 18828174
[TBL] [Abstract][Full Text] [Related]
3. Properties of a herpes simplex virus multiple immediate-early gene-deleted recombinant as a vaccine vector.
Watanabe D; Brockman MA; Ndung'u T; Mathews L; Lucas WT; Murphy CG; Felber BK; Pavlakis GN; Deluca NA; Knipe DM
Virology; 2007 Jan; 357(2):186-98. PubMed ID: 16996101
[TBL] [Abstract][Full Text] [Related]
4. Deletion of multiple immediate-early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neurons.
Krisky DM; Wolfe D; Goins WF; Marconi PC; Ramakrishnan R; Mata M; Rouse RJ; Fink DJ; Glorioso JC
Gene Ther; 1998 Dec; 5(12):1593-603. PubMed ID: 10023438
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
6. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma.
Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC
Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368
[TBL] [Abstract][Full Text] [Related]
7. Replication-defective genomic HSV gene therapy vectors: design, production and CNS applications.
Burton EA; Fink DJ; Glorioso JC
Curr Opin Mol Ther; 2005 Aug; 7(4):326-36. PubMed ID: 16121698
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
9. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
11. Development and application of replication-incompetent HSV-1-based vectors.
Berto E; Bozac A; Marconi P
Gene Ther; 2005 Oct; 12 Suppl 1():S98-102. PubMed ID: 16231061
[TBL] [Abstract][Full Text] [Related]
12. Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo.
Marconi P; Simonato M; Zucchini S; Bregola G; Argnani R; Krisky D; Glorioso JC; Manservigi R
Gene Ther; 1999 May; 6(5):904-12. PubMed ID: 10505116
[TBL] [Abstract][Full Text] [Related]
13. Intra-articular delivery of a herpes simplex virus IL-1Ra gene vector reduces inflammation in a rabbit model of arthritis.
Oligino T; Ghivizzani S; Wolfe D; Lechman E; Krisky D; Mi Z; Evans C; Robbins P; Glorioso J
Gene Ther; 1999 Oct; 6(10):1713-20. PubMed ID: 10516720
[TBL] [Abstract][Full Text] [Related]
14. Comparative analyses of transgene delivery and expression in tumors inoculated with a replication-conditional or -defective viral vector.
Ichikawa T; Chiocca EA
Cancer Res; 2001 Jul; 61(14):5336-9. PubMed ID: 11454670
[TBL] [Abstract][Full Text] [Related]
15. Tumor growth inhibition by intratumoral inoculation of defective herpes simplex virus vectors expressing granulocyte-macrophage colony-stimulating factor.
Toda M; Martuza RL; Rabkin SD
Mol Ther; 2000 Oct; 2(4):324-9. PubMed ID: 11020347
[TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
[TBL] [Abstract][Full Text] [Related]
17. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
18. Multiple applications for replication-defective herpes simplex virus vectors.
Burton EA; Wechuck JB; Wendell SK; Goins WF; Fink DJ; Glorioso JC
Stem Cells; 2001; 19(5):358-77. PubMed ID: 11553845
[TBL] [Abstract][Full Text] [Related]
19. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
[TBL] [Abstract][Full Text] [Related]
20. Gene transfer with herpes simplex vectors.
Lachmann RH; Efstathiou S
Curr Opin Mol Ther; 1999 Oct; 1(5):622-32. PubMed ID: 11249669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]